However, if the pathogen is not promptly eliminated, the regulation of adiponectin secretion becomes compromised in patients with metabolic disorders, leading to sustained elevation of adiponectin levels and consequent long-lasting anti-inflammatory response. This evidence concerns the gene ADIPOQ and metabolic disease.